Carmichael Hill & Associates’s Sabra Healthcare REIT SBRA Stock Holding History

Carmichael Hill & Associates’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-497	Closed	-$7K	–	836
2022 Q3	$7K	Hold	497	–	–	﹤0.01%	633
2022 Q2	$7K	Hold	497	–	–	﹤0.01%	620
2022 Q1	$7K	Hold	497	–	–	﹤0.01%	657
2021 Q4	$7K	Hold	497	–	–	﹤0.01%	673
2021 Q3	$7K	Hold	497	–	–	﹤0.01%	656
2021 Q2	$9K	Sell	497 -235	-32%	-$4.18K	﹤0.01%	613
2021 Q1	$13K	Hold	732	–	–	0.01%	558
2020 Q4	$13K	Hold	732	–	–	0.01%	535
2020 Q3	$10K	Hold	732	–	–	0.01%	531
2020 Q2	$11K	Hold	732	–	–	0.01%	492
2020 Q1	$8K	Sell	732 -65	-8%	-$1.2K	0.01%	492
2019 Q4	$17K	Buy	+797	New	+$17.8K	0.01%	421

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $9.67B AUM 5.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Carmichael Hill & Associates's SBRA Position: Q4 2022 in Review

Carmichael Hill & Associates sold out of Sabra Healthcare REIT (SBRA) in Q4 2022, closing a stake of 497 shares — an estimated $7K sold.

Carmichael Hill & Associates first reported a position in SBRA in Q4 2019 and held it in 12 quarters. The position peaked at $17K in Q4 2019. 327 funds tracked by Wall St. Rank hold SBRA as of Q4 2022.

Carmichael Hill & Associates reported no remaining Sabra Healthcare REIT position as of Q4 2022 after selling out during the quarter.
Carmichael Hill & Associates sold 497 Sabra Healthcare REIT shares in Q4 2022, an estimated $7K.
Carmichael Hill & Associates first reported a position in Sabra Healthcare REIT in Q4 2019 and held it in 12 quarters.
Carmichael Hill & Associates's Sabra Healthcare REIT position peaked at $17K in Q4 2019.
327 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2022.

Based on Carmichael Hill & Associates's 13F filing for Q4 2022, filed 14 Feb 2023.